Recent shortages an example of America’s over-bearing dependence on Chinese supply chains. The time is now to take action to reverses this decades-long headwind to U.S. manufacturing and its labor force.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Lawyers from Wiley are telling their clients to prepare for ongoing supply disruptions due to Biden’s China policies.
A Hudson Institute webinar suggests that the U.S. is in a better position to take on China than Europe.
Biden’s new tax proposal benefits renewable energy. But where tax credits are concerned, can individuals and companies that get those tax credits then use the capital to import green tech from China? What’s stopping them?
The Department of Commerce heard a panel of industry leaders on Thursday discussing the shortage in semiconductors, and asks why we can’t make this stuff at home.
What’s in Biden’s corporate tax plan? The good news is that it looks like small and mid-sized businesses will be left unscathed.
We are heading for a trillion-dollar deficit this year in manufactured goods unless some serious import substitution takes place.
With jobs being added back to the U.S. economy after nearly a year of economic restrictions, higher paying wages are leading to an improvement in the Job Quality Index. The index, created by researchers and economists from Cornell University and the Coalition for a Prosperous America hit 81.99 in March, up by 0.48% from its…
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.